Yuan‐Tso Cheng

837 total citations
60 papers, 582 citations indexed

About

Yuan‐Tso Cheng is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuan‐Tso Cheng has authored 60 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 18 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuan‐Tso Cheng's work include Bladder and Urothelial Cancer Treatments (26 papers), Urinary and Genital Oncology Studies (17 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). Yuan‐Tso Cheng is often cited by papers focused on Bladder and Urothelial Cancer Treatments (26 papers), Urinary and Genital Oncology Studies (17 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). Yuan‐Tso Cheng collaborates with scholars based in Taiwan, United States and China. Yuan‐Tso Cheng's co-authors include Hao‐Lun Luo, Po‐Hui Chiang, Yao‐Chi Chuang, Po Hui Chiang, Yen‐Ta Chen, Chih‐Hsiung Kang, Yen-Ta Chen, Vikas R. Dharnidharka, Kevin C. Abbott and Robert Neff and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Yuan‐Tso Cheng

59 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuan‐Tso Cheng Taiwan 13 304 172 154 94 73 60 582
Eugene J. Pietzak United States 15 655 2.2× 182 1.1× 219 1.4× 254 2.7× 109 1.5× 89 869
Cinzia Giacometti Italy 15 91 0.3× 68 0.4× 235 1.5× 83 0.9× 26 0.4× 33 494
Hironori Yamashita Japan 13 182 0.6× 159 0.9× 134 0.9× 81 0.9× 9 0.1× 49 485
Alexandre Balaphas Switzerland 12 258 0.8× 52 0.3× 55 0.4× 104 1.1× 10 0.1× 43 451
Jun Zou United States 10 108 0.4× 67 0.4× 208 1.4× 73 0.8× 13 0.2× 26 541
James Celebrezze United States 11 372 1.2× 389 2.3× 112 0.7× 116 1.2× 6 0.1× 25 666
Takayoshi Sekikawa Japan 13 333 1.1× 239 1.4× 249 1.6× 85 0.9× 17 0.2× 36 700
C.E.M. Blomjous Netherlands 11 253 0.8× 108 0.6× 110 0.7× 57 0.6× 54 0.7× 18 414
Takeshi Tono Japan 14 397 1.3× 196 1.1× 243 1.6× 70 0.7× 4 0.1× 90 783
Jeffrey H. Loose United States 8 149 0.5× 48 0.3× 71 0.5× 53 0.6× 5 0.1× 10 372

Countries citing papers authored by Yuan‐Tso Cheng

Since Specialization
Citations

This map shows the geographic impact of Yuan‐Tso Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan‐Tso Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan‐Tso Cheng more than expected).

Fields of papers citing papers by Yuan‐Tso Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan‐Tso Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan‐Tso Cheng. The network helps show where Yuan‐Tso Cheng may publish in the future.

Co-authorship network of co-authors of Yuan‐Tso Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan‐Tso Cheng. A scholar is included among the top collaborators of Yuan‐Tso Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan‐Tso Cheng. Yuan‐Tso Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Yuan‐Tso, Liwen Han, Yi Tang, & Lingling Wang. (2025). Xiaoyaosan inhibits liver metastases of colorectal cancer in vivo by regulating neutrophil extracellular traps formation. Traditional Medicine Research. 10(8). 46–46. 1 indexed citations
2.
Cheng, Yuan‐Tso, et al.. (2024). The impact of setup errors on dose distribution in cervical cancer radiotherapy and the margin from CTV to PTV. Journal of Cancer Research and Clinical Oncology. 150(12). 516–516.
3.
4.
Kang, Chih‐Hsiung, et al.. (2023). MicroRNA-26a-5p Restoration Ameliorates Unilateral Ureteral Obstruction-Induced Renal Fibrosis in Mice Through Modulating TGF-β Signaling. Laboratory Investigation. 103(7). 100131–100131. 7 indexed citations
5.
Cheng, Yuan‐Tso, Y. H. Kao, Wan-Chi Tsai, et al.. (2022). MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A/β-catenin signaling. Scientific Reports. 12(1). 6955–6955. 9 indexed citations
6.
Cheng, Yuan‐Tso, et al.. (2020). Increased Serum Calcium Level Promotes the Risk of Lymph Node Metastasis in Endometrial Cancer. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Su, Yu‐Li, Hao‐Lun Luo, Chun‐Chieh Huang, et al.. (2020). Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival. Cells. 9(4). 806–806. 33 indexed citations
8.
Luo, Hao‐Lun, et al.. (2019). Preventive Role of mTOR Inhibitor in Post–Kidney Transplant Urothelial Carcinoma. Transplantation Proceedings. 51(8). 2731–2734. 3 indexed citations
9.
Liu, Ying‐Chieh, et al.. (2018). Delayed Initiation of Tacrolimus Is Safe and Effective in Renal Transplant Recipients With Delayed and Slow Graft Function. Transplantation Proceedings. 50(8). 2368–2370. 7 indexed citations
10.
Chiang, Po‐Hui, Hao‐Lun Luo, Yao‐Chi Chuang, et al.. (2016). Determine of the optimal number of cycles of docetaxel in the treatment of metastatic castration‐resistant prostate cancer. The Kaohsiung Journal of Medical Sciences. 32(9). 458–463. 2 indexed citations
11.
12.
Liu, Yiyang, et al.. (2014). Predictors of Prostate-Specific Antigen Biochemical Recurrence in Patients Undergoing Primary Whole-Gland Prostate Cryoablation. Annals of Surgical Oncology. 22(5). 1612–1617. 9 indexed citations
13.
Cheng, Yuan‐Tso, et al.. (2013). Risk factors of spontaneous hemorrhagic transformation after cerebral infarction. Chinese Journal of Neuromedicine. 12(1). 53–56. 2 indexed citations
14.
Luo, Hao‐Lun, et al.. (2012). Lymphovascular invasion is a pathological feature related to aggressive cancer behavior and predicts early recurrence in prostate cancer. The Kaohsiung Journal of Medical Sciences. 28(6). 327–330. 14 indexed citations
15.
Cheng, Yuan‐Tso, et al.. (2012). Adrenal myelolipoma: A 10‐year single‐center experience and literature review. The Kaohsiung Journal of Medical Sciences. 28(7). 377–382. 13 indexed citations
16.
Chen, Chien‐Hsu, Wei‐Chia Lee, Yao‐Chi Chuang, et al.. (2012). High‐intensity diode laser in combination with bipolar transurethral resection of the prostate: A new strategy for the treatment of large prostates (>80 ml). Lasers in Surgery and Medicine. 44(9). 699–704. 17 indexed citations
17.
Cheng, Yuan‐Tso, et al.. (2011). Efficacy and safety of photoselective vaporization of the prostate in patients with prostatic obstruction induced by advanced prostate cancer. Asian Journal of Surgery. 34(3). 135–139. 2 indexed citations
18.
Dharnidharka, Vikas R., Wida S. Cherikh, Robert Neff, Yuan‐Tso Cheng, & Kevin C. Abbott. (2010). Retransplantation After BK Virus Nephropathy in Prior Kidney Transplant: An OPTN Database Analysis. American Journal of Transplantation. 10(5). 1312–1315. 48 indexed citations
19.
Chen, Yen‐Ta, et al.. (2002). The outcome of post‐transplant transitional cell carcinoma in 10 renal transplant recipients. Clinical Transplantation. 16(6). 410–413. 38 indexed citations
20.
Cheng, Yuan‐Tso, et al.. (1997). Central nervous system infection due toClostridium septicum: A case report and review of the literature. Infection. 25(3). 171–174. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugene J. Pietzak Breakdown of academic impact, for papers by Cinzia Giacometti Breakdown of academic impact, for papers by Hironori Yamashita Breakdown of academic impact, for papers by Alexandre Balaphas Breakdown of academic impact, for papers by Jun Zou Breakdown of academic impact, for papers by James Celebrezze Breakdown of academic impact, for papers by Takayoshi Sekikawa Breakdown of academic impact, for papers by C.E.M. Blomjous Breakdown of academic impact, for papers by Takeshi Tono Breakdown of academic impact, for papers by Jeffrey H. Loose
Rankless by CCL
2026